Tsukuba, Japan

Kazuhiro Ohgi


Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2000-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kazuhiro Ohgi: Innovator in Galanin Receptor Research

Introduction

Kazuhiro Ohgi is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of biotechnology, particularly in the area of galanin receptor research. With a total of 2 patents, his work has implications for various therapeutic applications.

Latest Patents

Ohgi's latest patents focus on DNA encoding a galanin receptor and the associated galanin receptor proteins. These patents detail the production and use of galanin receptor proteins, including methods for screening galanin receptor agonists and antagonists. The inventions provide a means to efficiently screen for compounds that can act as agonists or antagonists of the galanin receptor, which is crucial for developing pharmaceuticals aimed at treating conditions such as stomach ulcers, diabetes, Alzheimer's disease, and dementia. The patents also cover pharmaceutical compositions containing these compounds and antibodies against the galanin receptor protein.

Career Highlights

Kazuhiro Ohgi is currently employed at Takeda Chemical Industries, Inc., where he continues to advance his research in receptor proteins. His work has been instrumental in understanding the role of galanin receptors in various diseases, paving the way for innovative treatment options.

Collaborations

Ohgi has collaborated with notable colleagues, including Shuji Hinuma and Ryo Fujii. Their combined expertise has contributed to the successful development of his patented technologies.

Conclusion

Kazuhiro Ohgi's contributions to the field of galanin receptor research highlight his role as an influential inventor. His patents not only advance scientific understanding but also hold promise for future therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…